Dr. Matthew Gregory Mcknight is a Saint Charles, Illinois based Oral and Maxillofacial Surgeon who is specialized in Oral and Maxillofacial Surgery. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 2580 Foxfield Rd Ste 100, Saint Charles. Patients can reach him at 630-377-7077.
Dr. Matthew Gregory Mcknight deals with the diagnosis, surgical and adjunctive treatment of diseases, injuries and defects involving both the functional and esthetic aspects of the hard and soft tissues of the oral and maxillofacial region.
Complete Profile:
Dr. Matthew Gregory Mcknight speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Dr. Matthew Gregory Mcknight
Specialization:
Oral and Maxillofacial Surgeon
Gender:
Male
Credentials:
D.D.S., M.D.
Accepts Medicare Assignment:
May Accept
Practice Address:
2580 Foxfield Rd Ste 100, Saint Charles, Illinois, 60174-1411
Phone:
630-377-7077
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
PAC ID:
1759681083
Enrollment ID:
I20151118001417
NPI Number:
1518250125
NPI Enumeration Date:
16 May, 2011
NPI Last Update On:
05 Aug, 2020
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2580 Foxfield Rd Ste 100, Saint Charles, Illinois
Zip:
60174-1411
Phone Number:
630-377-7077
Patients can reach Dr. Matthew Gregory Mcknight at 2580 Foxfield Rd Ste 100, Saint Charles, Illinois or can call to book an appointment on 630-377-7077. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.